James T. Patterson

James T. Patterson

Auto-generated profile, based on publicly available information

James T. Patterson

Sorrento Therapeutics, Inc., 4955 Directors Place, San Diego, CA 92121, USA

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 July 2009 in Nature Chemical Biology
Verified
Journal Article
Closed access
PDF file
JDJonathan W Day
Jonathan W Day
NONickki Ottaway
Nickki Ottaway
JPJames T Patterson
James T Patterson
VGVasily Gelfanov
Vasily Gelfanov
DSDavid Smiley
David Smiley
MTMatthias H Tschöp
Matthias H Tschöp

15 July 2013 in American Journal of Physiology-Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
RKRamya S. Kuna
Ramya S. Kuna
SGShravan Babu Girada
Shravan Babu Girada
SASuman Asalla
Suman Asalla
JVJoyprashant Vallentyne
Joyprashant Vallentyne
SMSubbareddy Maddika
Subbareddy Maddika
PMPrasenjit Mitra
Prasenjit Mitra
Glucagon-like peptide-1 receptor (GLP-1R) plays a major role in promoting glucose-stimulated insulin secretion in pancreatic β-cells. In the present study, we synthesized a novel functional analog of GLP-1 conjugated to tetramethyl rhodamine to monitor the internalization of the receptor. Our data show that after being internalized the receptor is sorted to lysosomes. In endosomes, receptor-ligand complex is found to be colocalized with adenylate cyclase. Pharmacological inhibition of endocytosis attenuates GLP-1R-mediated cAMP generation and consequent downstream protein kinase A substrate phosphorylation and glucose-stimulated insulin secretion. Our study underlines a paradigm shift in GLP-1R signaling and trafficking. The receptor ligand complex triggers cAMP generation both in plasma membrane and in endosomes, which has implications for receptor-mediated regulation of insulin secretion.

6 May 2009 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
RNRuben Nogueiras
Ruben Nogueiras
DPDiego Pérez-Tilve
Diego Pérez-Tilve
CVChristelle Veyrat-Durebex
Christelle Veyrat-Durebex
DMDonald A. Morgan
Donald A. Morgan
LVLuis Varela
Luis Varela
MTMatthias H. Tschöp
Matthias H. Tschöp
We investigated a possible role of the central glucagon-like peptide (GLP-1) receptor system as an essential brain circuit regulating adiposity through effects on nutrient partitioning and lipid metabolism independent from feeding behavior. Both lean and diet-induced obesity mice were used for our experiments. GLP-1 (7–36) amide was infused in the brain for 2 or 7 d. The expression of key enzymes involved in lipid metabolism was measured by real-time PCR or Western blot. To test the hypothesis that the sympathetic nervous system may be responsible for informing adipocytes about changes in CNS GLP-1 tone, we have performed direct recording of sympathetic nerve activity combined with experiments in genetically manipulated mice lacking β-adrenergic receptors. Intracerebroventricular infusion of GLP-1 in mice directly and potently decreases lipid storage in white adipose tissue. These effects are independent from nutrient intake. Such CNS control of adipocyte metabolism was found to depend partially on a functional sympathetic nervous system. Furthermore, the effects of CNS GLP-1 on adipocyte metabolism were blunted in diet-induced obese mice. The CNS GLP-1 system decreases fat storage via direct modulation of adipocyte metabolism. This CNS GLP-1 control of adipocyte lipid metabolism appears to be mediated at least in part by the sympathetic nervous system and is independent of parallel changes in food intake and body weight. Importantly, the CNS GLP-1 system loses the capacity to modulate adipocyte metabolism in obese states, suggesting an obesity-induced adipocyte resistance to CNS GLP-1.

20 January 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JLJia Liu
Jia Liu
TGThomas Gaj
Thomas Gaj
JPJames T. Patterson
James T. Patterson
SSShannon J. Sirk
Shannon J. Sirk
CICarlos F. Barbas Iii
Carlos F. Barbas Iii
Transcription activator-like (TAL) effector nucleases (TALENs) have enabled the introduction of targeted genetic alterations into a broad range of cell lines and organisms. These customizable nucleases are comprised of programmable sequence-specific DNA-binding modules derived from TAL effector proteins fused to the non-specific FokI cleavage domain. Delivery of these nucleases into cells has proven challenging as the large size and highly repetitive nature of the TAL effector DNA-binding domain precludes their incorporation into many types of viral vectors. Furthermore, viral and non-viral gene delivery methods carry the risk of insertional mutagenesis and have been shown to increase the off-target activity of site-specific nucleases. We previously demonstrated that direct delivery of zinc-finger nuclease proteins enables highly efficient gene knockout in a variety of mammalian cell types with reduced off-target effects. Here we show that conjugation of cell-penetrating poly-Arg peptides to a surface-exposed Cys residue present on each TAL effector repeat imparted cell-penetrating activity to purified TALEN proteins. These modifications are reversible under reducing conditions and enabled TALEN-mediated gene knockout of the human CCR5 and BMPR1A genes at rates comparable to those achieved with transient transfection of TALEN expression vectors. These findings demonstrate that direct protein delivery, facilitated by conjugation of chemical functionalities onto the TALEN protein surface, is a promising alternative to current non-viral and viral-based methods for TALEN delivery into mammalian cells.

19 February 2016 in Chemical Science
Verified
Journal Article
Open access
PDF file
SKS. Kalhor-Monfared
S. Kalhor-Monfared
MJM. R. Jafari
M. R. Jafari
JPJ. T. Patterson
J. T. Patterson
PKP. I. Kitov
P. I. Kitov
JDJ. J. Dwyer
J. J. Dwyer
RDRatmir Derda
Ratmir Derda
In this manuscript, we describe modification of Cys-residues in peptides and proteins in aqueous solvents via aromatic nucleophilic substitution (SNAr) with perfluoroarenes (fAr).

6 June 2010 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
DPDiego Perez-Tilve
Diego Perez-Tilve
SHSusanna M Hofmann
Susanna M Hofmann
JBJoshua Basford
Joshua Basford
RNRuben Nogueiras
Ruben Nogueiras
PPPaul T Pfluger
Paul T Pfluger
MTMatthias H Tschöp
Matthias H Tschöp